CASE OF LEFLUNOMIDE-INDUCED CLINICAL AND MORPHOLOGICAL REGRESSION OF AA-AMYLOIDOSIS AND REMISSION OF ADULT-ONSET STILL'S DISEASE
https://doi.org/10.14412/1995-4484-2015-456-459
Abstract
The paper describes a long-term observation and discusses the possible mechanism of leflunomide-induced clinical and morphological regression of AA-amyloidosis diagnosed at a nephrotic stage in the presence of adult-onset Still's disease.
About the Authors
Yu. V. Muravyev
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia 34A, Kashirskoe Shosse, Moscow 115522
Russian Federation
Russian Federation
A. V. Alekseeva
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia 34A, Kashirskoe Shosse, Moscow 115522
Russian Federation
Russian Federation
S. G. Radenska-Lopovok
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia 34A, Kashirskoe Shosse, Moscow 115522
Russian Federation
Russian Federation
V. V. Lebedeva
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia 34A, Kashirskoe Shosse, Moscow 115522
Russian Federation
Russian Federation
References
1. Муравьев ЮВ, Алексеева АВ, Раденска-Лоповок СГ. АА-амилоидоз при болезни Стилла, развившейся у взрослых. Научно-практическая ревматолог Still’s disease, develop in adults. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2011;(3):95–8 (In Russ.)].
2. Harington TM, Moran JJ, Davis DE. Amyloidosis in adult onset Still's disease. J Rheumatol. 1981;8(5):833–6.
3. Elkon KB, Hughes GRV, Bywaters EGL, et al. Adult onset Still's disease. Twenty-year follow up and further studies ofpatients with active disease. Arthritis Rheum. 1982;25(6):647–54. doi: 10.1002/art.1780250607
4. Vigneron AM, Kaplan G, Labrousse C, et al. Amylose au cours de la maladie de Still de l'adulte. Arthritis Rheum. 1982;25(6):647–54.
5. Cush JJ, Medsger TA, Christy WC, et al. Adult onset Still's disease. Clinical course and outcome. Arthritis Rheum. 1987;30(2):186–94. doi: 10.1002/art.1780300209
6. Reginato AJ, Shumacher HR, Baker D, et al. Adult onset Still's disease: Experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum. 1987;17(1):39–57. doi: 10.1016/0049-0172(87)90015-1
7. Wendling D, Philippe GH, Billerey C, et al. Adult onset Still's disease and related renal amyloidosis. Ann Rheum Dis. 1991;50(4):257–9. doi: 10.1136/ard.50.4.257
8. Bamberym P, Kaur U, Bhusnurmath SR, et al. Adult onset Still's disease in north India. Rheumatol Int. 1987;7(4):173–6. doi: 10.1007/BF00270366
9. Cabane J, Michon A, Ziza JM, et al. Comparison of long term evolution of adult onset and juvenile onset Still's disease, both followed up for more than 10 years. Ann Rheum Dis. 1990;49(5):283. doi: 10.1136/ard.49.5.283
10. Migita K, Miyashita T, Maeda Y, et al. An active metabolite of leflunomide, A77 1726, inhibits the production of serum amyloid A protein in human hepatocytes. Rheumatology (Oxford). 2005;44(4):443–8. doi: 10.1093/rheumatology/keh462
11. Lachmann HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356(23):2361–71. doi: 10.1056/NEJMoa070265
12. Kennedy WR. Renal amyloidosis. Can Med Assoc J. 1935;33(4):385–8.
13. Trasoff A, Schneeberg N, Scarf M. Recovery from multiple rheumatoid arthritis complicated by amyloidosis in a child. Arch Intern Med. 1944;74:4. doi: 10.1001/archinte. 1944.00210190012002
14. Parkins RA, Bywaters EG. Regression of amyloidosis secondary to rheumatoid arthritis. Br Med J. 1959;1(5121):536–40. doi: 10.1136/bmj.1.5121.536
15. Komatsuda A, Morita K, Ohtani H, et al. Remission of the nephrotic syndrome in a patient with renal amyloidosis due to rheumatoid arthritis treated with prednisolone and methotrexate. Am J Kidney Dis. 1998 Nov;32(5):E7. doi: 10.1016/S0272-6386(98)70154-4
16. Shapiro DL, Spiera H. Regression of the nephrotic syndrome in rheumatoid arthritis and amyloidosis treated with azathioprine. A case report. Arthritis Rheum. 1995 Dec;38(12):1851–4. doi:
17. 1002/art.1780381220
18. Falck HM, Tö rnroth T, Skrifvars B, Wegelius O. Resolution of renal amyloidosis secondary to rheumatoid arthritis. Acta Med Scand. 1979;205(7):651–6. doi: 10.1111/j.0954-6820.1979.tb06121.x
19. Tanaka F, Migita K, Honda S, et al. Clinical outcome and survival of secondary (AA) amyloidosis. Clin Exp Rheumatol. 2003;21:343-6.
20. Okuda Y, Takasugi K, Oyama T, et al. Intractable diarrhea associated with secondary amyloidosis in rheumatoid arthritis. Ann Rheum Dis. 1997;56:535–41. doi: 10.1136/ard.56.9.535
21. Kuroda T, Tanabe N, Harada T, et al. Long-term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritis. Clin Rheumatol. 2006;25:498–505. doi: 10.1007/s10067-005-0079-z
22. Насонов ЕЛ. Внедрение высоких медицинских технологий в ревматологии: проблемы и решения. Научно-практическая ревматология. 2008;(2):4–5 [Nasonov EL. The introduction of advanced medical technology in rheumatology: Problems and Solutions. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2008;(2):4–5 (In Russ.)].
23. Elkayam O, Hawkins PN, Lachmann H, et al. Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab. Arthritis Rheum. 2002;46:2571–3. doi: 10.1002/art.10581
24. Kuroda T, Tanabe N, Kobayashi D, et al. Treatment with biologic agents improves the prognosis of patients with rheumatoid arthritis and amyloidosis. J Rheumatol. 2012;39(7):1348–54. doi: 10.3899/jrheum.111453
Review
For citations:
Muravyev Yu.V., Alekseeva A.V., Radenska-Lopovok S.G., Lebedeva V.V. CASE OF LEFLUNOMIDE-INDUCED CLINICAL AND MORPHOLOGICAL REGRESSION OF AA-AMYLOIDOSIS AND REMISSION OF ADULT-ONSET STILL'S DISEASE. Rheumatology Science and Practice. 2015;53(4):456-459. (In Russ.) https://doi.org/10.14412/1995-4484-2015-456-459
Views:
735
Email this article 